Soleno Therapeutics (SLNO) Amortizatization of Intangibles (2015 - 2026)
Soleno Therapeutics (SLNO) reported Amortizatization of Intangibles of $221000.0 for Q1 2026, down 77.45% year-over-year from $980000.0 in Q1 2025, and down 81.46% on a QoQ basis from $1.2 million in Q4 2025.
Soleno Therapeutics (SLNO) has 4 years of Amortizatization of Intangibles data on file, last reported at $221000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 77.45% year-over-year to $221000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (down 48.94% YoY) and the FY2025 annual result came in at $3.5 million, down 28.15% from the prior year.
- Amortizatization of Intangibles fell to $221000.0 in Q1 2026 per SLNO's latest filing, from $1.2 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.9 million in Q3 2024 and bottomed at $221000.0 in Q1 2026.
- The 3-year median for Amortizatization of Intangibles is $980000.0 (2025), against an average of $959222.2.
- Peak annual rise in Amortizatization of Intangibles reached 107.19% in 2025, while the deepest fall reached 80.57% in 2025.
- Tracing SLNO's Amortizatization of Intangibles over 3 years: stood at $1.4 million in 2024, then decreased by 14.86% to $1.2 million in 2025, then plunged by 81.46% to $221000.0 in 2026.
- Per Business Quant, the three latest SLNO Amortizatization of Intangibles figures stand at $221000.0 (Q1 2026), $1.2 million (Q4 2025), and $371000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 221,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221,000.00 |
| Mar 31, 2026 | 221,000.00 |
| Dec 31, 2025 | 1.19 Mn |
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | 371,000.00 |
| Sep 30, 2025 | 371,000.00 |
| Jun 30, 2025 | 974,000.00 |
| Jun 30, 2025 | 974,000.00 |
| Mar 31, 2025 | 980,000.00 |
| Mar 31, 2025 | 980,000.00 |
| Dec 31, 2024 | 1.40 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Mar 31, 2024 | 473,000.00 |
| Mar 31, 2024 | 473,000.00 |
| Dec 31, 2015 | -11,000.00 |
| Dec 31, 2015 | -11,000.00 |